跳至主要内容
临床试验/NCT01663363
NCT01663363已完成3 期

A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser

Abbott Medical Optics0 个研究点目标入组 170 人开始时间: 2012年8月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
170
主要终点
Percentage of Eyes With Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)

研究概览

简要总结

The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •18 years of age or greater
  • •Best Spectacle Corrected Visual Acuity (BSCVA) of 20/20 or better
  • •Uncorrected visual acuity (UCVA) of 20/40 or worse
  • •Less than 0.75D difference between cycloplegic and manifest refraction sphere.
  • •Demonstration of refractive stability
  • •Anticipated post-operative stromal bed thickness of at least 250 microns
  • •Willing and capable of returning for follow-up examinations for the duration of the study.

排除标准

  • •Women who are pregnant, breast-feeding, or intend to become pregnant over the course of the study
  • •Concurrent use of topical or systemic medications that may impair healing
  • •History of any medical conditions that could affect wound healing
  • •History of prior intraocular or corneal surgery, active ophthalmic disease, or other ocular abnormality
  • •Evidence of keratoconus, corneal irregularity, or abnormal topography in the operative eye(s)
  • •Known sensitivity or inappropriate responsiveness to any of the medications used in the post-operative course

研究组 & 干预措施

wavefront-guided LASIK

Experimental

LASIK correction of myopic refractive errors. Surgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System.

干预措施: LASIK correction of myopic refractive errors (Device)

结局指标

主要结局

Percentage of Eyes With Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)

时间窗: 6 Months

次要结局

  • Percentage of Eyes With Uncorrected Visual Acuity (UCVA) of 20/40 or Better(6 Months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验